I Tepler
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
Papers in
-
- Hematopoietic Stem Cell Transplantation 7
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 2
- Co-authors
- ANTHONY D. ELIAS (9 shared papers)Lois Jeanne Ayash (8 shared papers)Rosemary Mazanet (8 shared papers)Gary N. Schwartz (6 shared papers)Philip Leder (4 shared papers)Catherine Wheeler (4 shared papers)Kenneth Carl Anderson (3 shared papers)Mary Ellen Moynahan (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Stem Cells (1 paper)Blood (1 paper)Annals of Oncology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
I Tepler
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 52
- Hematology 354
- Oncology 361
- Cancer Research 173
- Pathology and Forensic Medicine 89
- Immunology 102
Countries citing papers authored by I Tepler
This map shows the geographic impact of I Tepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Tepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Tepler more than expected).
Fields of papers citing papers by I Tepler
This network shows the impact of papers produced by I Tepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Tepler. The network helps show where I Tepler may publish in the future.
Co-authors
The 25 scholars most cited alongside I Tepler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 332 | |
| 2 | 1992 | 228 | |
| 3 | 1994 | 125 | |
| 4 | 1988 | 106 | |
| 5 | Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. | 1989 | 85 |
| 6 | 1993 | 73 | |
| 7 | High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. | 1997 | 53 |
| 8 | 1993 | 48 | |
| 9 | Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. | 1995 | 32 |
| 10 | 1989 | 27 | |
| 11 | 1994 | 16 | |
| 12 | Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer. | 1997 | 16 |
| 13 | The gene for the human mast cell high-affinity IgE receptor alpha chain: chromosomal localization to Iq21-q23 and RFLP analysis. | 1989 | 10 |
| 14 | High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age. | 1994 | 8 |
| 15 | 1995 | 7 | |
| 16 | Low-dose vincristine-associated bilateral vocal cord paralysis. | 1999 | 7 |
| 17 | High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions. | 1994 | 6 |
| 18 | 1992 | 5 | |
| 19 | 2026 | 0 |
About I Tepler
I Tepler is a scholar working on Hematology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), Mast cells and histamine (3 papers), Cancer therapeutics and mechanisms (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Neutropenia and Cancer Infections (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (354 citations), Oncology (361 citations), Cancer Research (173 citations), Pathology and Forensic Medicine (89 citations) and Immunology (102 citations). I Tepler has collaborated with scholars based in United States and Switzerland. Frequent co-authors include ANTHONY D. ELIAS, Lois Jeanne Ayash, Rosemary Mazanet, Gary N. Schwartz, Philip Leder, Catherine Wheeler, Kenneth Carl Anderson, Mary Ellen Moynahan, Violante E. Currie and Marc Jeffrey Gollub. Their work appears in journals such as Journal of Clinical Oncology, Stem Cells, Blood, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.